Clinical trial / 2021
Whole-body cryotherapy improved immediate recall, orientation, and mood measures in participants with mild cognitive impairment.
In a prospective randomised double-blind sham-controlled trial, 62 participants with mild cognitive impairment were allocated to whole-body cryotherapy (-110 °C to -160 °C; n = 33) or a placebo control group (n = 29). After the 10th session (T2), significant differences favored the cryotherapy group in immediate recall (DemTect) and orientation (TYM). Improvements in mood were detected in self-reported depressive symptoms (T2 p = 0.04; VAS mood T2 p = 0.02; T3 p = 0.07), alongside a significant reduction in BDNF level (p < 0.05).
- Study type
- Prospective randomised double-blind sham-controlled study
- Who was studied
- 62 participants with mild cognitive impairment (MoCA between 20 and 26)
- What was measured
- Cognitive functions, quality of life, well-being, depressive symptoms, cytokines, neurotrophins, and biochemical parameters
THE PAPER
The improvement of cognitive deficits after whole-body cryotherapy - A randomised controlled trial.
Rymaszewska J, Lion KM, Stańczykiewicz B, Rymaszewska JE, Trypka E, Pawlik-Sobecka L, Kokot I, Płaczkowska S, Zabłocka A, Szcześniak D. Exp Gerontol, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.